Delivery Order SPE2DE24D0021-SPE2D625F8J0V
- Not listed
- Fisher Scientific Company L.L.C. was awarded a $3,956.00 delivery order contract on June 18, 2025, for kit real-time polymerase chain reaction (RT PCR) RNA with 1 step builtin hot start gel. This fixed-price contract with economic price adjustment has an ultimate completion date of July 1, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Medical Supply Chain, a defense-focused federal agency, with no set-aside designation applied. As a child contract...
- Fisher Scientific Company L.L.C., a major supplier of laboratory and medical equipment to federal agencies, received a $2,140.14 fixed-price delivery order from the Defense Department's Medical Supply Chain division on June 18, 2025. The contract covers procurement of a kit for real-time polymerase chain reaction (PCR) DNA polymerase, single-step substrate, and related 3-plate configuration materials. Performance will take place in Pittsburgh, Pennsylvania, with an ultimate completion date of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,911.80 on September 3, 2025, for the supply of a kit for reverse transcription polymerase chain reaction (RT PCR) 96-well plate region of interest testing. The contract is a fixed price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 15, 2025. The award was made without a set-aside designation through open competition, and performance will take place in...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,230.00 on August 22, 2025, for the procurement of a kit containing real-time polymerase chain reaction (PCR) DNA primer with a single-step protocol and probe for detection purposes. The contract, which is fixed price with economic price adjustment pricing, is classified as a child contract and was issued without a set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, with an ultimate completion...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,325.12 on October 1, 2025, for the supply of a kit for real-time polymerase chain reaction (PCR) in 5 milliliter fast-speed advanced master mix with TaqMan chemistry. The contract is fixed-price with economic price adjustment provisions and carries an ultimate completion date of October 14, 2025. This delivery order was issued without set-aside designation, reflecting open competition procurement practices. The award is...
- Fisher Scientific Company L.L.C. has been awarded a fixed-price delivery order valued at $6,420.42 for one kit of real-time polymerase chain reaction (PCR) DNA primer with single-step substrate and caption plates, to be delivered to Pittsburgh, Pennsylvania. The contract was awarded on August 28, 2025, with an ultimate completion date of September 17, 2025. This delivery order represents a child contract with no set-aside designation, awarded through open competition to support the Medical...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $10,700.70 on June 6, 2025, for the supply of PCR DNA polymerase kit components with single-step substrate script 3 plating capabilities. The contract, which extends through June 30, 2025, supports the Defense Medical Supply Chain and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger procurement vehicle and was awarded through open competition with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,260.00 on August 15, 2025, for the procurement of kit reverse transcription polymerase chain reaction (RT-PCR) reagents with reduced ribonucleic acid (RNA) activity. This fixed-price delivery order with economic price adjustment falls under the Defense or Civilian agency designation of Medical Supply Chain and is scheduled for completion by August 29, 2025. The contract represents a child award and does not utilize a...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $10,700.70 on August 13, 2025, for the supply of SSIII 1-Step QRT-PCR 500 quantitative reverse transcription polymerase chain reaction testing kits. The contract, which represents a child award under a larger vehicle, is funded by the Defense Medical Supply Chain and is scheduled for completion by September 4, 2025. Performance will take place in Pittsburgh, Pennsylvania. No small business set-aside was...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,485.00 for SSIII 1-Step QRT-PCR 100 supplies under a fixed-price contract with economic price adjustment provisions. The contract was awarded on June 2, 2025, with an ultimate completion date of June 24, 2025, and will be performed in Pittsburgh, Pennsylvania. This award was issued by the Medical Supply Chain division within the Department of Defense and represents an open competition procurement with no set-aside...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F8J0VDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $17,597.93 on May 19, 2025, for the procurement of kit real-time polymerase chain reaction (PCR) RNA with one step built-in hot start gel supplies. This fixed-price delivery order with economic price adjustment has an ultimate completion date of May 30, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Medical Supply Chain agency, a defense-focused federal entity, through an open competition with no set-aside designation. As a major supplier of laboratory and scientific equipment to federal agencies, Fisher Scientific is well-positioned to deliver specialized testing solutions; the company has demonstrated extensive capabilities across multiple scientific domains through numerous prior contract awards with agencies including the National Institutes of Health, Department of Veterans Affairs, and the Food and Drug Administration. This delivery order represents a child contract within a larger acquisition framework and supports the government's laboratory and diagnostic testing capabilities. Fisher Scientific's substantial presence in the federal marketplace, including a $1.65 million Blanket Purchase Agreement with the Department of Veterans Affairs for toxicology and drugs of abuse reagents, underscores the company's role as a critical vendor for medical and scientific supply chain operations. The procurement of PCR RNA kits with integrated hot-start capabilities aligns with standard laboratory diagnostic and research protocols, enabling rapid and efficient molecular testing across federal facilities and medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.6k | 5/19/25 |